Common Contracts
4 similar Underwriting Agreement contracts by Conseco Inc, Insulet Corp, Macrogenics Inc, Viking Therapeutics, Inc.
6,471,000 Shares VIKING THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 1st, 2024 • Viking Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned understands that Morgan Stanley & Co. LLC and Leerink Partners LLC (collectively, the “Representatives”), propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Viking Therapeutics, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including the Representatives (the “Underwriters”), of shares (the “Shares”) of the common stock, $0.00001 par value per share, of the Company (the “Common Stock”).
2,369,668 Shares INSULET CORPORATION COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 15th, 2020 • Insulet Corp • Surgical & medical instruments & apparatus • New York
MACROGENICS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 2nd, 2018 • Macrogenics Inc • Pharmaceutical preparations • New York
45,000,000 Shares CONSECO, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2010 • Conseco Inc • Accident & health insurance • New York
Conseco, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), an aggregate of 45,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Firm Shares”).
